| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |